catalog number :
MBS601015
products full name :
HLA Class 1 Antigen B17,B35,B44(X-Reactive)
products short name :
[HLA Class 1 Antigen B17,B35,B44(X-Reactive)]
products name syn :
[Anti -HLA Class 1 Antigen B17,B35,B44(X-Reactive)]
specificity :
Recognizes human HLA Class 1Antigen-B17,B35,B44. Additional cross reactivity occurs with related proteins. Specificity was determined at a 1:10 dilution by the microcytotoxicity test under standard NIH conditions.
form :
Supplied as a lyophilized powder. Reconstitute with 100ul sterile ddH2O to make a 10X stock solution.
storage stability :
Lyophilized and reconstituted products are stable for 12 months after receipt at -20°C. Reconstitute with sterile dH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
tested application :
Microcytotoxicity Test
app notes :
This antibody has not been tested in methodologies other than Microcytotoxicity Test. Potential applications include Flow Cytometry, Cell Typing, Tissue Staining and Chimerism Studies.
other info2 :
Directions for Use: For a cytotoxic working dilution, add 0.9ml of 1% BSA in PBS to 100ul of10X working stock. Store aliquots at -20°C. Expected Values: Cell death will occur in any test well where the HLA cell surface antigen is recognized by its matched anti-HLA antibody. Live lymphocytes indicate a negative reaction. Dead lymphocytes indicate a positive reaction. Limitations: Cell isolation difficulties, contamination of the lymphocyte preparation with red blood cells, monocytes, platelets or granulocytes, cell concentrations outside acceptable levels, bacterial contamination and/or change in pH of antisera may cause erroneous results.
products categories :
Antibodies; Abs to HLA
products description :
HLA CLass I is involved in the presentation of foreign antigens to the immune system. This antibody is a valuable reagent for analysing variations in HLA class I expression in different disease states e.g. liver disease, muscular dystrophy, inflammatory myopathy and other neuromuscular disorders.